What if clinical trial sites could focus entirely on research? What if sponsors could have immediate access to trial patients during and after the study, and use those insights to improve trial design? What if all of that could be done without burdening an already strained site? What if those didn’t have to be “what ifs”?  

In this sponsored episode of The Top Line, Julia Douthart talks to Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, about how new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.

But can it be done without adding an additional technological burden and learning curve on the site staff? Listen to learn how IQVIA is addressing these challenges.

Listen to other 'The Top Line' episodes here. 

Learn more about IQVIA here. 

What if clinical trial sites could focus entirely on research? What if sponsors could have immediate access to trial patients during and after the study, and use those insights to improve trial design? What if all of that could be done without burdening an already strained site? What if those didn’t have to be “what ifs”?  
In this sponsored episode of The Top Line, Julia Douthart talks to Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, about how new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.
But can it be done without adding an additional technological burden and learning curve on the site staff? Listen to learn how IQVIA is addressing these challenges.
Listen to other 'The Top Line' episodes <a href="https://www.fiercepharma.com/keyword/top-line">here</a>. 
Learn more about IQVIA <a href="https://www.iqvia.com/solutions/research-and-development/clinical-trials">here</a>.

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

IQVIA’s new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.

Advertisement